Publications

Journal Article Ahead of print

PubMed: 41687243 DOI: 10.1016/j.clbc.2026.01.010

Contralateral Risk Reduction Mastectomy in Patients With Unilateral Breast Cancer Scheduled for Mastectomy: A Multidisciplinary Survey; Physicians' Perspective.

Clin Breast Cancer 26(3):44-53

Authors: Nina M Verghis, Kazim Senol, Shigeru Imoto, Claudine OrdoƱez, Kristin Lupinacci, Jamila Alazhri, Alexander Mundinger, Carole Mathelin, Vahit Ozmen, Atilla Soran

Affiliations

  • Breast Surgery Unit, Department of Surgical Oncology, UPMC Magee-Womens Hospital, Pittsburgh, PA.
  • Uludağ University Medical Department of Surgery, Breast Surgery Clinic, Bursa Türkiye.
  • Department of Breast Surgery, Kyorin University School of Medicine, Kyorin, Japan.
  • Felicidad Claudia R. OrdoƱez, Breast Surgery, Cardinal Santos MC, Manila, Philippines.
  • Breast Surgery, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
  • Breast Imaging and Interventions, Niels-Stensen-Kliniken; Franziskus Hospital, Georgsmarienhuette, Germany.
  • Surgery Department, ICANS, Strasbourg, France.
  • Sisli Florence Nightingale Hospital, Breast Center, Istanbul, Türkiye.
  • Breast Surgery Unit, Department of Surgical Oncology, UPMC Magee-Womens Hospital, Pittsburgh, PA.

Abstract

INTRODUCTION

The number of contralateral risk reduction mastectomies (RRM) continues to rise. Despite the existence of many guidelines, there is no general consensus on which patients should be considered for RRM. This survey was distributed among various breast specialists with the goal of evaluating current practices, perspectives, and attitudes towards RRM.

METHODS

An English-language survey containing ten questions was designed and distributed electronically to members of the Senologic International Society (SIS). The findings of this survey align with existing research and also provide areas for further investigation.

RESULTS

This survey demonstrates the different practices and viewpoints on RRM across various specialties and areas around the world. These variations highlight the need for uniform recommendations and further research to enhance patient outcomes and address the challenges of managing RRM patients.

MeSH

Mastectomy, Breast Neoplasms, Neoplasms, Breast, Physicians, Research, Unilateral Breast Neoplasms